Summary of Significant Accounting Policies - Schedule of Concentration (Details)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Janssen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	23.00%		30.00%
Janssen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	31.00%	15.00%	30.00%
Biogen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	9.00%	19.00%	11.00%
Biogen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	11.00%	13.00%	10.00%
Cardinal Health | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	24.00%	24.00%	17.00%
Cardinal Health | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	20.00%	24.00%	20.00%
AmerisourceBergen | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	16.00%	18.00%	13.00%
AmerisourceBergen | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	12.00%	14.00%	11.00%
McKesson | Accounts Receivable | Credit Concentration Risk
Product Information [Line Items]
Concentration risk percentage	14.00%	12.00%	11.00%
McKesson | Revenues Net | Customer Concentration Risk
Product Information [Line Items]
Concentration risk percentage	14.00%	16.00%	13.00%